RESUMEN

Objetivo. Estudio retrospectivo de casos de listeriosis en mujeres gestantes diagnosticadas en el Hospital Universitario Sant Joan de Déu de Barcelona los años 2000-2010. Material y métodos. Inclusión de todas aquellas gestantes que consultan por clínica sugestiva de listeriosis y posterior confirmación de la infección mediante cultivos. Análisis descriptivo. Resultados. 18 casos de listeriosis diagnosticados (incidencia 4/10.000). En un 94,5% no se hallan factores de riesgo conocidos. En el 45% el signo guía es la fiebre materna. En los 2 casos diagnosticados prenatalmente y que se realiza tratamiento antibiótico, se produce parto a término sin secuelas neonatales (100%). La morbimortalidad materno-fetal tras la infección por Listeria monocytogenes es del 44,5%, produciéndose secuelas importantes en el 11% de recién nacidos vivos y un 33,5% de éxitus fetales. Conclusiones. A pesar de la baja incidencia de la listeriosis, es importante su diagnóstico precoz, ya que un tratamiento adecuado reduce la morbimortalidad materno-fetal (AU)

Objective. We performed a restrospective study of cases of listeriosis diagnosed in pregnant women in the Hospital Sant Joan de Déu from 2000 to 2010. Material and methods. All pregnant women who consulted for symptoms suggestive of listeriosis and with culture-confirmed infection were included. A descriptive statistical analysis was performed. Results. Eighteen cases of listeriosis were diagnosed (incidence 4/10000). In 94.5%, there were no associated risk factors. In 45% of the patients, the main sign was maternal fever. Two patients who were diagnosed prenatally and who received antibiotic therapy delivered at term without neonatal effects (100%). Maternal and fetal morbidity and mortality after Listeria monocytogenes infection was 44.5%, with important sequelae in 11% of the neonates and fetal exitus in 33.5%. Conclusion. Despite the low incidence of listeriosis, early diagnosis is important, since correct treatment reduces maternal and fetal morbidity and mortality (AU)

Asunto(s)

RESUMEN

OBJETIVO: El objetivo de este trabajo es analizar los resultados obtenidos en nuestro centro en pacientes seleccionadas, con factores de riesgo de recidiva del prolapso genital. MÉTODOS: Serie de casos que incluye un total de 76 pacientes intervenidas, desde Julio del 2005 hasta Diciembre del 2009, de prolapso genital severo, con factores de riesgo de recidiva del prolapso genital. RESULTADOS: En el grupo Prolift® anterior se detectan, durante el seguimiento, 3 casos (6.8%) de recidiva sintomática del prolapso y 6 casos (13.6%) de aparición de prolapso de otro compartimento. En el grupo Prolift® posterior no se produce ningún caso de recidiva, pero existen 2 (10,52%) casos de prolapso de otro compartimento. En el caso del Prolift® total existen 2 (16.6%) casos de recidiva sintomática del prolapso. En cuanto a la urgencia miccional de novo: existen un total de 4 (5.33%) casos. 3 de ellos pertenecientes a la malla Prolift® anterior y 1 a la malla Prolift® total. No hemos detectado ningún caso de dolor, pélvico o en los puntos de inserción de la malla, severo que haya obligado a la reintervención por persistencia del mismo. CONCLUSIONES: El uso de mallas en la cirugía reconstructiva del suelo pélvico, en pacientes seleccionadas, con factores clínicos de riesgo de recidiva, es una buena opción de tratamiento para evitar o intentar disminuir las tasas de recidiva o reintervención descritas en la actualidad(AU)

OBJECTIVE: The aim of this paper is to analyze the results obtained in pelvic floor surgery using a non-absorbable mesh in selected patients with risk factors of recurrent prolapse. METHODS: Case series including a total of 76 patients who were surgically treated for severe genital prolapse from July 2005 to December 2009, with risk factors for recurrence of genital prolapse. RESULTS: We detected 3 cases (6.8%) of symptomatic prolapse recurrence and 6 cases (13.6%) of prolapse of another compartment in the anterior Prolift® group. In the posterior Prolift® group there were no recurrences but there were 2 cases (10.52%) of prolapse of another compartment. In the total Prolift® group, there were 2 cases (16.6%) of symptomatic prolapse recurrence. As for de novo urgency, there were a total of 4 cases (5.33%), 3 in the anterior Prolift® group and 1 in the total Prolift ® group. We did not detect any case of severe pain in the pelvis or mesh insertion points that required reoperation due to persistence. CONCLUSIONS: The use of mesh in pelvic floor reconstructive surgery in selected patients with risk factors for recurrence is a good treatment option to prevent or attempt to reduce the recurrence or reoperation rates currently described(AU)

Asunto(s)

RESUMEN

OBJECTIVE: The aim of this paper is to analyze the results obtained in pelvic floor surgery using a non-absorbable mesh in selected patients with risk factors of recurrent prolapse. METHODS: Case series including a total of 76 patients who were surgically treated for severe genital prolapse from July 2005 to December 2009, with risk factors for recurrence of genital prolapse. RESULTS: We detected 3 cases (6.8%) of symptomatic prolapse recurrence and 6 cases (13.6%) of prolapse of another compartment in the anterior Prolift® group. In the posterior Prolift® group there were no recurrences but there were 2 cases (10.52%) of prolapse of another compartment. In the total Prolift® group, there were 2 cases (16.6%) of symptomatic prolapse recurrence. As for de novo urgency, there were a total of 4 cases (5.33%), 3 in the anterior Prolift® group and 1 in the total Prolift® group. We did not detect any case of severe pain in the pelvis or mesh insertion points that required reoperation due to persistence. CONCLUSIONS: The use of mesh in pelvic floor reconstructive surgery in selected patients with risk factors for recurrence is a good treatment option to prevent or attempt to reduce the recurrence or reoperation rates currently described.

Asunto(s)